Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Papa John's upgrade, AT&T downgrade among top calls on Wall Street » 09:56
04/01/20
04/01
09:56
04/01/20
09:56
PZZA

Papa John's

$54.05 /

+0.68 (+1.27%)

, DPZ

Domino's Pizza

$314.41 /

-9.3 (-2.87%)

, DLTR

Dollar Tree

$71.48 /

-2 (-2.72%)

, DG

Dollar General

$150.25 /

-1.02 (-0.67%)

, T

AT&T

$28.31 /

-0.86 (-2.95%)

, PEP

PepsiCo

$116.50 /

-3.53 (-2.94%)

, STZ

Constellation Brands

$137.50 /

-5.88 (-4.10%)

, TAP

Molson Coors

$37.24 /

-1.71 (-4.39%)

, SAM

Boston Beer

$353.13 /

-12.3 (-3.37%)

, MNST

Monster Beverage

$52.93 /

-3.32 (-5.90%)

, KDP

Keurig Dr Pepper

$23.95 /

-0.32 (-1.32%)

, CCEP

Coca-Cola European Partners

$36.25 /

-1.245 (-3.32%)

, KO

Coca-Cola

$43.04 /

-1.2 (-2.71%)

, JPM

JPMorgan

$85.60 /

-4.7 (-5.20%)

, BNY

BlackRock New York Municipal Income Trust

$13.15 /

+0.26 (+2.02%)

, C

Citi

$39.40 /

-2.8 (-6.64%)

, STT

State Street

$50.45 /

-2.73 (-5.13%)

Check out today's top…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Boston Beer resumed with a Buy at Goldman Sachs » 05:47
04/01/20
04/01
05:47
04/01/20
05:47
SAM

Boston Beer

$365.43 /

+1.43 (+0.39%)

Goldman Sachs analyst…

Goldman Sachs analyst Bonnie Herzog resumed coverage of Boston Beer with a Buy rating and $415 price target. The analyst believes Boston Beer is "advantageously levered" to one of the few "big" growth opportunities in alcoholic beverages, hard seltzers.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
Upgrade
Boston Beer upgraded to Outperform from Sector Perform at RBC Capital » 06:44
03/23/20
03/23
06:44
03/23/20
06:44
SAM

Boston Beer

$308.74 /

-7.44 (-2.35%)

RBC Capital analyst Nik…

RBC Capital analyst Nik Modi upgraded Boston Beer to Outperform from Sector Perform with a price target of $424, up from $346. The analyst believes that the stock is "truly dislocated", with its multiple having contracted by 25% since February 19th, which suggests that the market is pricing in a nearly 30% earnings risk. Modi adds that his view of EPS risk is closer to 3%-5% as the company should be "relatively insulated" from currently market dynamics given that only 15% of its sales are on-premise.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Boston Beer upgraded to Outperform from Sector Perform at RBC Capital » 06:23
03/23/20
03/23
06:23
03/23/20
06:23
SAM

Boston Beer

$308.74 /

-7.44 (-2.35%)

RBC Capital analyst Nik…

RBC Capital analyst Nik Modi upgraded Boston Beer to Outperform from Sector Perform with a price target of $424, up from $346.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Molson Coors upgraded to Hold from Underperform at Jefferies » 08:13
03/20/20
03/20
08:13
03/20/20
08:13
TAP

Molson Coors

$38.49 /

-1.94 (-4.80%)

, STZ

Constellation Brands

$123.22 /

+1.805 (+1.49%)

, STZ.B

Constellation Brands; also tag STZ

$110.00 /

+ (+0.00%)

, SAM

Boston Beer

$316.18 /

-4.16 (-1.30%)

Jefferies analyst Kevin…

Jefferies analyst Kevin Grundy upgraded Molson Coors (TAP) to Hold from Underperform with a price target of $40, down from $45, citing his view that contraction in on-premise sales has been reasonably discounted while interest in its new seltzers is high and productivity will provide some offset to demand weakness. In the same note on the hard seltzer category, Grundy said he is still bullish on the category outlook, but he noted that his survey findings pointed to low brand loyalty and a high willingness to try new seltzer brands. He has also lowered his price target on Boston Beer (SAM) shares to $280 from $325 and cut his price target for Constellation Brands (STZ) to $225 from $265.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Boston Beer upgraded to Buy from Neutral at MKM Partners » 07:31
03/17/20
03/17
07:31
03/17/20
07:31
SAM

Boston Beer

$310.56 /

-28.585 (-8.43%)

MKM Partners analyst Bill…

MKM Partners analyst Bill Kirk upgraded Boston Beer to Buy from Neutral with an unchanged $351 price target. The analyst notes that the company is not expected to experience much "operational volatility" from the current fundamental uncertainty as the beer industry typically holds up well during weak economic periods. Kirk adds that Boston Beer grew every quarter during the recession, and consumers' off-premise consumption offers a neutralizing substitute to on-premise sales losses. The analyst warns that the biggest risk to his upgrade would be a disruption at company-owned or 3rd party production facilities.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Boston Beer upgraded to Buy from Neutral at MKM Partners » 05:48
03/17/20
03/17
05:48
03/17/20
05:48
SAM

Boston Beer

$310.56 /

-28.585 (-8.43%)

MKM Partners analyst Bill…

MKM Partners analyst Bill Kirk upgraded Boston Beer to Buy from Neutral with an unchanged price target of $351.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Recommendations
Boston Beer price target riased to $495 from $450 at Cowen » 07:55
02/20/20
02/20
07:55
02/20/20
07:55
SAM

Boston Beer

$430.18 /

+3.925 (+0.92%)

Cowen analyst Vivien Azer…

Cowen analyst Vivien Azer raised her price target on Boston Beer to $495 from $450 following Q4 results. The analyst noted its big beat but said spending is clearly going up as management looks for opportunities, such that consensus is at the high-end of guidance. Azer reiterated her Outperform rating on Boston Beer shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: After Hours Movers » 19:10
02/19/20
02/19
19:10
02/19/20
19:10
STMP

Stamps.com

$95.39 /

+3.33 (+3.62%)

, SREV

ServiceSource

$1.87 /

+0.005 (+0.27%)

, Z

Zillow

$54.43 /

+2.15 (+4.11%)

, CAR

Avis Budget

$43.35 /

+2.01 (+4.86%)

, CYH

Community Health

$4.80 /

+0.1 (+2.13%)

, NE

Noble Corp.

$0.82 /

-0.0129 (-1.55%)

, MANT

ManTech

$81.82 /

+0.29 (+0.36%)

, XEC

Cimarex Energy

$40.55 /

+1.675 (+4.31%)

, CYBE

Cyberoptics

$23.28 /

+1.165 (+5.27%)

, UCTT

Ultra Clean

$26.26 /

+1.01 (+4.00%)

, TRN

Trinity Industries

$22.09 /

+0.065 (+0.30%)

, MX

MagnaChip

$14.44 /

+0.19 (+1.33%)

, IMAX

Imax

$17.12 /

+0.03 (+0.18%)

, SM

SM Energy

$9.25 /

+0.51 (+5.84%)

, GDOT

Green Dot

$35.27 /

+1.09 (+3.19%)

, SNBR

Sleep Number

$56.72 /

+0.47 (+0.84%)

, PXD

Pioneer Natural

$141.16 /

+5.62 (+4.15%)

, SPN

Superior Energy

$5.05 /

-0.515 (-9.26%)

, LASR

nLight

$19.99 /

+1.46 (+7.88%)

, AJRD

Aerojet Rocketdyne

$53.10 /

-0.33 (-0.62%)

, SUN

Sunoco LP

$30.34 /

-0.22 (-0.72%)

, MASI

Masimo

$182.31 /

+0.96 (+0.53%)

, ALB

Albemarle

$88.97 /

+0.3 (+0.34%)

, TVTY

Tivity Health

$22.91 /

+0.06 (+0.26%)

, OSUR

OraSure

$7.13 /

+0.56 (+8.52%)

, NVTA

Invitae

$27.48 /

+0.27 (+0.99%)

, SAM

Boston Beer

$430.18 /

+3.925 (+0.92%)

, BCOV

Brightcove

$9.24 /

+0.4 (+4.52%)

, LOPE

Grand Canyon

$86.85 /

+0.95 (+1.11%)

, SPTN

SpartanNash

$13.31 /

-0.01 (-0.08%)

, UAN

CVR Partners

$2.60 /

-0.07 (-2.62%)

, CRMT

America's Car-Mart

$126.76 /

+4.93 (+4.05%)

, QTWO

Q2 Holdings

$87.67 /

+0.38 (+0.44%)

, INOV

Inovalon

$22.25 /

+0.1 (+0.45%)

, SNPS

Synopsys

$165.03 /

+2.12 (+1.30%)

, RETA

Reata Pharmaceuticals

$223.48 /

-4.325 (-1.90%)

, CAKE

Cheesecake Factory

$40.80 /

+0.64 (+1.59%)

, CONE

CyrusOne

$65.95 /

-0.97 (-1.45%)

, VMI

Valmont

$154.38 /

+3.01 (+1.99%)

, JACK

Jack in the Box

$88.83 /

+0.66 (+0.75%)

, H

Hyatt

$89.89 /

+1.15 (+1.30%)

, TS

Tenaris

$20.68 /

+0.49 (+2.43%)

, AXGT

Axovant

$4.45 /

+0.15 (+3.49%)

, BTAI

BioXcel Therapeutics

$41.16 /

+1.385 (+3.48%)

, HRTX

Heron Therapeutics

$21.66 /

+0.525 (+2.48%)

, IRT

Independence Realty Trust

$16.30 /

-0.01 (-0.06%)

, TEVA

Teva

$13.46 /

+1.145 (+9.30%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: Stamps.com (STMP) up 31.4%... ServiceSource (SREV) up 16.1%... Zillow Group (Z) up 15.1%... Avis Budget (CAR) up 12.3%... Community Health (CYH) up 11.0%... Noble Corp (NE) up 11.0%... ManTech (MANT) up 9.4%... Cimarex Energy (XEC) up 8.2%... CyberOptics (CYBE) up 7.8%... Ultra Clan (UCTT) up 7.3%... Trinity Industries (TRN) up 6.3%... MagnaChip Semi (MX) up 4.8%... Imax Corp (IMAX) up 3.8%... SM Energy (SM) up 3.6%... Green Dot (GDOT) up 3.2%... Sleep Number (SNBR) up 3.0%... Pioneer Natural (PXD) up 2.7%... Superior Energy (SPN) up 2.7%... nLight (LASR) up 2.6%... Aerojet Rocketdyne (AJRD) up 2.6%... Sunoco (SUN) up 2.4%... Masimo Corp (MASI) up 1.5%... Albemarle (ALB) up 1.3%. DOWN AFTER EARNINGS: Tivity Health (TVTY) down 33.7%... OraSure Technologies (OSUR) down 15.7%... Invitae (NVTA) down 10.9%... Boston Beer Co (SAM) down 9.1%... Brightcove (BCOV) down 8.7%... Grand Canyon Education (LOPE) down 7.2%... Grand Canyon Education (LOPE) down 7.2%... SpartanNash (SPTN) down 6.2%... CVR Partners (UAN) down 5.5%... America's Carmart (CRMT) down 3.5%... Q2 Holdings (QTWO) down 3.2%... Inovalon (INOV) down 3.2%... Synopsys (SNPS) down 3.0%... Reata Pharma (RETA) down 2.3%... Cheesecake Factory (CAKE) down 2.2%... CyrusOne (CONE) down 2.1%... Valmont Industries (VMI) down 2.0%... Jack in the Box (JACK) down 1.8%... Hyatt (H) down 1.3%... Tenaris (TS) down 1.3%. ALSO LOWER: Axovant Gene Therapies (AXGT) down 11.6% after equity offering... BioXcel Therapeutics (BTAI) down 10.1% after equity offering... Heron Therapeutics (HRTX) down 8.6% after FDA extended review period for HTX-011 NDA... Independence Realty Trust (IRT) down 4.6% after equity offering... Teva Pharma (TEVA) down 4.1% after Phase 2/3 trials in deutetrabenazine failed to meet the primary endpoints. Movers as of 18:30ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20
    Feb
  • 20
    Feb
Earnings
Boston Beer sees 2020 non-GAAP EPS $10.70-$11.70, consensus $11.71 » 16:33
02/19/20
02/19
16:33
02/19/20
16:33
SAM

Boston Beer

$430.18 /

+3.925 (+0.92%)

Sees 2020 CapEx…

Sees 2020 CapEx $135M-$155M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.